SETD2

SET domain containing 2, histone lysine methyltransferase

Summary

Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein belonging to a class of huntingtin interacting proteins characterized by WW motifs. This protein is a histone methyltransferase that is specific for lysine-36 of histone H3, and methylation of this residue is associated with active chromatin. This protein also contains a novel transcriptional activation domain and has been found associated with hyperphosphorylated RNA polymerase II. [provided by RefSeq, Aug 2008]

Known Variants996 total

rsidPosition (GRCh37)AllelesClassClinVar
rs20380141363:47,058,593T/C—uncertain significance
rs21074843973:47,058,596G/A—likely benign
rs7685640003:47,058,618C/T—conflicting classifications of pathogenicity
rs7736064683:47,058,629T/G—likely benign
rs10420581003:47,058,636T/C—uncertain significance
rs3687611153:47,058,653T/G—likely benign
rs9027946593:47,058,670C/T—likely benign
rs12480812793:47,058,676C/T—likely benign
rs10647956613:47,058,745C/A—pathogenic
rs12449943483:47,059,146A/G—likely benign
rs1484998353:47,059,161G/A—likely benign
rs7721359643:47,059,193G/A—uncertain significance
rs21074881523:47,059,194G/A—likely benign
rs8953748083:47,059,197A/T—likely benign
rs1418527783:47,059,214C/T—conflicting classifications of pathogenicity
rs12215365393:47,059,215G/A—likely benign
rs7611505523:47,059,217T/C—uncertain significance
rs11738465573:47,059,233C/G—uncertain significance
rs3743129053:47,059,239G/A—likely benign
rs23858673:47,059,323C/T—benign
rs1501637513:47,059,331T/A—likely benign
rs22905473:47,061,183G/C—benign
rs25453767303:47,061,247T/A—uncertain significance
rs7754879783:47,061,307T/C—likely benign
rs7757804023:47,061,326G/A—conflicting classifications of pathogenicity
rs5877786673:47,061,329G/A—not provided
rs7769866283:47,061,334A/C—likely benign
rs105107523:47,061,453C/T—benign
rs177841273:47,061,700T/Cintron variant—
rs117077363:47,069,504G/Tintron variant—
rs67687223:47,079,112G/A—benign
rs3699515543:47,079,150A/G—conflicting classifications of pathogenicity
rs25454125473:47,079,157T/C—uncertain significance
rs5590451623:47,079,160A/G—uncertain significance
rs25454125733:47,079,163G/A—uncertain significance
rs12701691873:47,079,174A/G—likely benign
rs1408286003:47,079,201A/G—likely benign
rs7604692633:47,079,216G/A—likely benign
rs2012856123:47,079,222A/G—benign
rs7511187233:47,079,236T/C—uncertain significance
rs761323933:47,079,245T/C—likely benign
rs25454128363:47,079,257A/G—uncertain significance
rs25454128433:47,079,264C/A—uncertain significance
rs3755571613:47,079,275G/A—likely benign
rs795458413:47,083,782C/G—likely benign
rs1391599603:47,083,998C/T—likely benign
rs15756762383:47,084,044C/T—likely benign
rs21075393923:47,084,079T/C—uncertain significance
rs12005735113:47,084,102T/C—uncertain significance
rs14682509233:47,084,121C/T—uncertain significance
rs1447524943:47,084,125G/A—likely benign
rs7715805793:47,084,146G/C—likely benign
rs20393344113:47,084,147G/T—uncertain significance
rs7681549883:47,084,152C/T—likely benign
rs1490255653:47,084,188A/C—likely benign
rs15756764723:47,084,195A/G—likely benign
rs1385353783:47,087,657G/A—likely benign
rs1446415213:47,087,742G/A—likely benign
rs130635783:47,087,837T/A—benign
rs781886453:47,087,849A/G—benign
rs7760561383:47,087,967C/T—likely benign
rs21075489403:47,087,979G/A—uncertain significance
rs8949150573:47,087,982G/C—likely benign
rs5529169283:47,087,992A/T—likely benign
rs7756320043:47,088,002G/T—uncertain significance
rs1402884613:47,088,004T/C—likely benign
rs2005257003:47,088,007A/G—benign
rs9953031253:47,088,012T/C—benign
rs1453772133:47,088,015T/C—likely benign
rs7658903893:47,088,026G/T—benign
rs1997392973:47,088,027C/A—conflicting classifications of pathogenicity
rs10245575433:47,088,036G/C—uncertain significance
rs7545889663:47,088,045C/A—uncertain significance
rs21075494773:47,088,047C/T—uncertain significance
rs20395396163:47,088,054G/A—conflicting classifications of pathogenicity
rs21075496233:47,088,071T/C—likely benign
rs21075496493:47,088,074T/C—uncertain significance
rs7492352533:47,088,076C/T—likely benign
rs12324344193:47,088,093G/C—uncertain significance
rs10189539673:47,088,094A/T—uncertain significance
rs14686497823:47,088,096T/C—uncertain significance
rs11627111973:47,088,105C/A—conflicting classifications of pathogenicity
rs20395432673:47,088,106A/G—likely benign
rs9647694813:47,088,120T/C—likely benign
rs7769687853:47,088,130A/C—likely benign
rs98314643:47,088,394A/C—benign
rs622464063:47,097,985G/C——
rs15536838383:47,098,306G/C—likely benign
rs3742285433:47,098,321G/C—uncertain significance
rs7705001123:47,098,324G/A—uncertain significance
rs7719575683:47,098,328T/C—uncertain significance
rs7620735783:47,098,332C/T—likely benign
rs25454596973:47,098,343G/A—uncertain significance
rs7733055133:47,098,357T/C—uncertain significance
rs7748108663:47,098,371T/C—likely benign
rs25454597913:47,098,373T/C—uncertain significance
rs11936564433:47,098,379C/T—uncertain significance
rs1504762393:47,098,389T/C—likely benign
rs7592194673:47,098,391T/C—benign
rs7635417663:47,098,405T/A—benign

Showing 100 of 996 variants. Use the SNP search for the full list.

Gene information from NCBI Gene. Variant classifications from ClinVar.

SETD2 — SET domain containing 2, histone lysine methyltransferase